BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2790326)

  • 21. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
    Leibovici L; Paul M; Cullen M; Bucaneve G; Gafter-Gvili A; Fraser A; Kern WV
    Cancer; 2006 Oct; 107(8):1743-51. PubMed ID: 16977651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Febrile neutropenia in cancer patients in a tertiary care medical center in Lebanon: microbial spectrum and outcome.
    Hamzeh F; Kanj SS; Uwaydah M
    J Med Liban; 2000; 48(3):136-42. PubMed ID: 11268566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prophylactic systemic antibiotherapy with only ceftriaxone in neutropenic patients treated in a protected environment].
    Harousseau JL; Milpied N; Reynaud AE; Derriennic M; Bourhis JH; Courtieu AL
    Pathol Biol (Paris); 1988 Sep; 36(7):907-11. PubMed ID: 3059275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
    Bow EJ; Mandell LA; Louie TJ; Feld R; Palmer M; Zee B; Pater J
    Ann Intern Med; 1996 Aug; 125(3):183-90. PubMed ID: 8686975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tolerability profile of prophylactic norfloxacin in neutropenic patients.
    Corrado ML; Struble WE; Hesney M
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S29-33. PubMed ID: 3280325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
    Herbrecht R; Blaise D; Espinouse D; Leblond V; Sadoun A; Sauvage C; Cordonnier C; Minozzi C
    J Chemother; 1995 Jun; 7 Suppl 2():103-10. PubMed ID: 8622099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants.
    Aksu G; Ruhi MZ; Akan H; Bengisun S; Ustün C; Arslan O; Ozenci H
    Bone Marrow Transplant; 2001 Jan; 27(2):201-5. PubMed ID: 11281391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients.
    Mossad SB; Longworth DL; Goormastic M; Serkey JM; Keys TF; Bolwell BJ
    Bone Marrow Transplant; 1996 Aug; 18(2):265-71. PubMed ID: 8864433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation.
    Schmeiser T; Kurrle E; Arnold R; Wiesneth M; Bunjes D; Hertenstein B; Kern W; Heit W; Heimpel H
    Scand J Infect Dis; 1988; 20(6):625-31. PubMed ID: 3065930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-drug oral antibacterial prophylaxis with ofloxacin in BMT recipients.
    Schmeiser T; Kern WV; Hay B; Hertenstein B; Arnold R
    Bone Marrow Transplant; 1993 Jul; 12(1):57-63. PubMed ID: 8374536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
    Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
    Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation.
    Dettenkofer M; Ebner W; Bertz H; Babikir R; Finke J; Frank U; Rüden H; Daschner FD
    Bone Marrow Transplant; 2003 May; 31(9):795-801. PubMed ID: 12732887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.
    De Pauw BE; Donnelly JP; De Witte T; Nováková IR; Schattenberg A
    Bone Marrow Transplant; 1990 Mar; 5(3):179-82. PubMed ID: 2184908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of gram-negative bacterial infection in granulocytopenic patients: a randomized study comparing oral norfloxacin with gentamycin.
    Nemet D; Kalenic S; Badanjak A; Bogdanic V; Davila N; Francetić I; Labar B
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():105. PubMed ID: 2697389
    [No Abstract]   [Full Text] [Related]  

  • 40. [An analysis of hospital bacterial infections in cirrhotic patients undergoing selective intestinal decontamination].
    Tomás A; Soriano G; Guarner C; Teixidó M; Méndez C; Tena F; Fábrega E; Villanueva C; Such J; Balanzó J
    Rev Esp Enferm Dig; 1991 Apr; 79(4):259-64. PubMed ID: 2054213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.